Displaying items by tag: division of pulmonary allergy and critical care medicine

UAB investigators have found a new pathway that contributes to an often fatal lung disease with no cure and no effective treatments, and possibly a way to shut that pathway down.

UAB treated the first patient in the nation in an experimental lung reduction procedure for emphysema.

Investigators have developed a new imaging method to enhance research into new treatments.

The latest edition of Best Doctors in America ® recognizes 325 UAB physicians — voted by their peers as the best.

Researchers at UAB have performed the first U.S. trial of a foam sealant injected into the lungs.

UAB-hosted seminar looking at the effects of air quality on human health.

CT scans can help physicians predict which COPD patients are likely to take a turn for the worse, say UAB researchers.

A new drug that improves lung function for some patients with cystic fibrosis may also help treat smokers with the incurable lung disease COPD.

The Program in Environmental and Translational Medicine combines clinical care with research to prevent, treat diseases caused from air pollution, water contamination, other causes.

UAB doctors can now employ a new procedure, using thermal energy, to open constricted airways in patients whose severe asthma is not controlled by medication.

UAB was a lead site in the testing of Kalydeco, the first drug to target the underlying genetic causes of cystic fibrosis.

A UAB researcher has received a grant to study idiopathic pulmonary fibrosis.

An antibiotic can help reduce acute COPD attacks and improve quality of life, a new study shows.

UAB is the first in the state to offer new procedure that uses thermal energy to help keep airways flowing freely.